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Às estrelas que me iluminam  
na mais escura hora  
e no mais claro dia. 
Que lhes mereça sempre a luz. 
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Abstract 
Over the last decades, epidemiological studies have been reporting worrisome trends in 
the incidence of human infertility rates. Extensive detection of industrial chemicals in 
human serum, seminal plasma, and follicular fluid has led the scientific community to 
hypothesize these compounds may disrupt hormonal homeostasis, leading to a vast 
array of physiological impairments that may cause developmental disorders, infertility 
and other detrimental effects. The main route of exposure to these ubiquitous chemicals 
is the ingestion of contaminated food and water. This review analyses the major 
scientific developments on the topic of human infertility associated with exposure to 
endocrine disruptors, incorporating evidence from epidemiological and experimental 
studies. Current data suggest endocrine disruptors can affect human fertility and 
reproductive function. They may easily disturb the intrauterine development of the 
reproductive system and central nervous system, in both genders, and they may also 
induce transgenerational effects. Endocrine disruptors may therefore be blamed for the 
rising incidence of human reproductive disorders and constitute a serious Public Health 
problem that should not be overlooked. The exposure of pregnant women and infants to 
endocrine disruptors is of great concern. Precautionary avoidance of exposure to 
endocrine disruptors is a prudent attitude. 
 
Abbreviations 
AFP: α-fetoprotein 
AGD: anogenital distance 
AhR: aryl hydrocarbon receptor 
AR: androgen receptor 
BPA: bisphenol A 
DDT: dichlorodiphenyltrichloroethane 
DES: diethylstilbestrol 
ED: endocrine disruptors 
EE: ethinyl oestradiol 
ER: oestrogen receptors 
FSH: follicle-stimulating hormone 
GnRH: gonadotropin-releasing hormone 
HPG axis: hypothalamus-pituitary-gonadal axis 
INSL3: insulin-like factor 3 
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IVF: in vitro fertilization 
kg-bw: kilogram of body weight 
LH: luteinizing hormone 
LOAEL: lowest observed adverse effect level 
MOF: multiple-oocyte follicles 
MXC: methoxychlor 
NSAID: nonsteroidal anti-inflammatory drugs 
ODS: ovarian dysgenesis syndrome 
PBDE: polybrominated diphenyl ethers 
PCB: polychlorinated biphenyls 
PCOS: polycystic ovary syndrome 
PG: prostaglandin 
POF: premature ovarian failure 
SHBG: sex hormone-binding globulin 
TCDD: 2,3,7,8-tetrachlorodibenzo-p-dioxin 
TDS: testicular dysgenesis syndrome 
TGF-β: transforming growth factor β 
VCZ: vinclozolin 
 
Introduction 
Infertility, which is currently defined as the inability to conceive after one year of 
unprotected intercourse, has a global prevalence of 9%, ranging from 3.5% to 16.7% in 
developed countries, compared to 6.9-9.3% in developing countries.1 A multi-centre 
study conducted by the World Health Organization among infertile couples shown that  
the cause was predominantly female in 38% of the cases and primarily male in 20%, 
while 27% of couples had both male and female abnormalities, and no evident cause 
was identified as for the remaining 15%.2 Since the mid-twentieth century, a cumulative 
number of studies report an increasing incidence of human reproductive diseases and 
consequent decline in reproductive function, in several locations and amongst different 
populations.3 Given this relatively short time frame, genetic changes may not explain 
the rising infertility rates. Thus, environmental substances may be one of the factors 
responsible for the observed geographical and populational differences in the incidence 
of infertility.4,5 
4 
 
Following the economic development brought forward by the beginning of the 
industrial era, which inexorably led to massive production and use of a wide variety of 
synthetic substances, drastic lifestyle changes have occurred. Both human and wildlife 
have ever since been exposed to numerous potentially hazardous chemicals that are 
released by industries into the environment at an alarming rate. These substances may 
have significant adverse reproductive outcomes attributable to their ubiquitous presence 
in the environment and multiple routes of exposure.6  
One of the most significant landmarks in Endocrinology of the past century is the 
recognition that some of these chemicals are able to disrupt the endocrine system, being 
named Endocrine Disruptors (ED).7 Consistent detection of ED residues in human 
serum, seminal plasma, and follicular fluid raised concern that environmental exposure 
to ED is affecting human fertility.8 Human exposure to some ED seems to be able to 
impair fertility without any other clinical signs of toxicity, suggesting that the main 
target of ED is the homeostasis of sex steroids.9,10 Though ED are not considered major 
teratogens, reproductive function – from gamete production and fertilization through 
intrauterine and post-natal development of the offspring – is believed to be particularly 
susceptible to endocrine disruption, triggering morphological and functional 
abnormalities, and even reproductive tract cancers.11,12 Still, there is much to be studied 
in order to substantiate an unequivocal relationship between ED exposure and 
reproductive and developmental disorders.  
The main purpose of this paper is to review and summarize the major scientific 
developments on the topic of human infertility associated to ED exposure, integrating 
evidence arising from human epidemiological studies and experimental studies in model 
organisms. Examples of well-known and hypothetical ED are selected to highlight the 
rationale for the potential effects of ED on human fertility, identifying future research 
directions. 
 
Methods 
The influence of ED exposure on human fertility reported in the PubMed database is 
reviewed. The PubMed database was used to search for articles published until 
December 31st 2012, using the following MeSH keyword-based query: endocrine AND 
[(disruptors OR disrupters) OR (disrupting AND (compounds OR chemicals))] AND 
(fertility OR infertility OR fecundity). Only studies using the English language were 
considered. Altogether, 332 papers were retrieved. The abstract of every article was 
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read. The leading review criterion was human epidemiological studies in which a link 
between ED exposure and infertility was evaluated. Owing to the scarcity of human 
experimental studies, animal models were also considered in this review, as it has been 
shown that humans are at least as sensitive to ED as the most sensitive animal species, 
and the reliability of experimental animal data regarding reproductive disruption has 
been well established.3 The full texts of the 214 selected articles were retrieved and 
read. Furthermore, the bibliographies from 41 selected review articles were also 
analysed, resulting in the inclusion of 153 other papers. In addition, 19 articles were 
included by authors’ suggestion. Overall, 249 articles out of the 386 read full texts were 
deemed relevant and included in this review. 
 
ED and Infertility 
From a physiological standpoint, an ED is a compound, either synthetic or natural, that, 
through environmental exposure, disrupts the hormonal and homeostatic systems, which 
allow organisms to interact with the environment and are responsible for developmental 
processes and reproduction, through a closed feedback loop.7 The group of known ED is 
extremely heterogeneous and embraces ubiquitous synthetic substances used as 
industrial lubricants and solvents, and their by-products: polychlorinated biphenyls 
(PCB),13 polybrominated diphenyl ethers (PBDE),14 and dioxins, such as 
2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD);15 plastics: bisphenol A (BPA);16 
plasticizers: phthalates;17 pesticides: atrazine,18 cypermethrin,19 
dichlorodiphenyltrichloroethane (DDT),20 dieldrin,21 methoxychlor (MXC),20 and 
vinclozolin (VCZ);22 and drugs: diethylstilbestrol (DES),23 ethinyl oestradiol (EE),24 
and nonsteroidal anti-inflammatory drugs (NSAID) and acetaminophen.25 Natural 
chemicals such as phytoestrogens,26 including genistein, and heavy metals27 can also 
have endocrine-disruptive effects.  
Although there has been an effort to list and rank all possible ED, the number of 
evaluated chemicals remains limited, in some cases because of technical restrictions 
regarding their detection.28,29 Therefore, most studies have focused on a small number 
of ED, for which reliable biomonitoring data are available, as proxies for the total 
exposure.30 The possible contribution of ED to many reproductive disorders has not 
been fully assessed because of scientific and ethical limitations. Moreover, as the 
interpretation of epidemiological studies is biased by many confounding factors, such 
studies must be supported by experimental research in animal models.3 
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Many documented ED are substances with oestrogenic or anti-androgenic activity, by 
interfering with the oestrogen receptors (ER) or the androgen receptor (AR) (see Table 
1). Given the complexity of the endocrine system as a whole, the mechanisms of action 
of ED are difficult to unravel. So far, endocrine disruption is known to ensue changes of 
hormone-regulated mechanisms arising from ED binding, as either agonists or 
antagonists, to nuclear receptors and membrane receptors (comprising nuclear sex 
steroid receptors, non-nuclear sex steroid receptors, nonsteroidal receptors, such as 
neurotransmitter receptors, and both nuclear and membrane orphan receptors), thus 
interfering with gene expression and cell signalling pathways. The relative influence of 
nuclear, membrane-associated, and cytosolic receptors to the vast array of detrimental 
effects arising from ED exposure remains unclear. Current data suggest ED (such as 
BPA) may have more potent effects through non-nuclear receptors.45 Some ED are also 
capable of modifying hormone bioavailability by interfering with its secretion and 
transport, as well as disrupting the enzymatic pathways involved in hormone synthesis 
and metabolism.46-48 Yet, one should keep in mind ED probably do not reproduce nor 
abolish hormonal actions entirely, as most of them are imperfect ligands to endogenous 
targets.49 Most ED are supposed to act through several mechanisms, which may have 
synergistic or antagonistic outcomes.50  
Proper gonadal differentiation, maturation, and function rely on both steroidal and 
non-steroidal signalling. A relationship between ED exposure, impaired fertility and 
altered gonadal TGF-β superfamily signalling has been suggested in alligators.51  
Apart from sex steroid receptors, the most studied receptor for interaction with ED is 
the aryl hydrocarbon receptor (AhR). This orphan receptor acts as a transcription factor 
for detoxifying enzymes and is thought to have evolved in response to sustained 
exposure to countless environmental chemicals.52 Moreover, the cross-talk between 
AhR and nuclear sex steroid receptors modifies gene transcription.53 Dioxins and some 
PCB exert their endocrine-disruptive effects through binding to AhR and impairing the 
usual gene transcription response.54 Additionally, owing to the ubiquitin-ligase activity 
of this receptor, AhR ligands enhance the degradation of substrate proteins such as ER 
and AR.55 
Traditionally, androgens are considered the male sex hormones and oestrogens, the 
female sex hormones. However, in either gender, androgens give rise to oestrogens, 
through aromatase, so together they play a vital role for homeostatic regulation in males 
and in females.56,57 Some ED interfere with aromatase (atrazine58 stimulates its activity, 
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while DDT and phthalates47 inhibit it), hence disrupting the delicate androgen-oestrogen 
balance required for proper reproductive function. Recently, many of the ED that lessen 
virilisation in experimental studies, such as phthalates and BPA, have been found to be 
powerful cyclooxygenase inhibitors, reducing prostaglandin (PG) synthesis, and this 
might be the foremost mechanism by which they exert their anti-androgenic effects.59  
The ability of an exogenous substance to modify hormonal actions is now regarded as a 
clear, intrinsic predictor of negative outcomes, which vary according to dose, time of 
exposure and the potency of that substance.49 Still, and despite the build-up of 
epidemiological human studies reporting higher infertility rates among those exposed to 
ED, the principle of endocrine disruption has always been controversial, mostly 
regarding the definition of the lowest observed adverse effect level (LOAEL) and 
whether these are likely to be found in vivo.60 Present postulated LOAEL for most ED 
are outdated.61 For instance, BPA has been found to induce detrimental reproductive 
effects in levels several-fold below current LOAEL, which is 50 mg/kg of body weight 
(kg-bw)/day.62,63 Perhaps expectably, there is a sharp division between those who are 
able to find significant effects of ED at low, environmentally relevant concentrations – 
mostly academic experts – and those who appear unable to show harmful effects of ED 
at any concentrations – industry corporations.64 Still, current data overall supports that 
minute environmental ED levels may have more potent effects than higher levels, and 
that ED may have nonlinear, biphasic, inverted U or U-shaped dose-response curves, 
owing to the blending of the outcomes of different mechanisms, that may change 
independently, accordingly to dose.61 Therefore, the existence of a threshold cannot be 
presumed.49 However, assuming equivalent exposures, the incidence of detrimental 
reproductive effects of some ED may be significantly higher in vulnerable individuals, 
owing to several factors, such as genetics, developmental stage when exposure occurs 
and pre-existing disease. Nonetheless, these issues remain controversial.65 
 
Human exposure to ED 
Populations are exposed to ED in air, water, food, and in a variety of industrial 
products, including personal care goods. Most individuals have traceable amounts of 
these substances in their serum or urine.3,30 For instance, over 90% of the North 
American population has measurable amounts of urinary BPA, and children have the 
highest levels, perhaps because they are the most exposed subpopulation to BPA and 
other ED.66  
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The major route of human exposure to ED is supposed to be ingestion of food and 
beverages contaminated with deliberately added compounds, including additives, 
processing aids, anabolic steroids used in food production, and monomers leaking from 
food containers;16,67 and also side products, impurities and other inadvertently added 
substances, such as pesticide residues and other pollutants,68 as well as heavy metals.27 
Current data suggest there is chronic and sustained exposure to ED such as BPA 
through inhalation, skin contact, and other routes as well.69 Direct occupational 
exposure to ED, such as pesticides and other industrial chemicals, is a known risk factor 
for reproductive disorders.11,70-72 
Humans and wildlife are exposed to fluctuating levels of ED, depending on production 
and utilization trends. The mixture of ED that leaches into soil and waterbodies (e.g. 
pesticides, contraceptive pills, and other industrial chemicals from urban and 
agricultural waste) accumulates in the environment and in animals higher up the food 
chain, due to the lipophilicity of these compounds and their resistance to 
biodegradation.6,73 Therefore, removal of these substances from the environment is 
neither simple nor cheap.74,75 Numerous ED are continuously detected in drinking water 
and food supplies, including meat, fish, dairy products and vegetables, and may 
therefore cause endocrine disruption in both humans and wildlife, long after their 
release into the environment.6,7,11 Indeed, some ED that have been banned decades ago, 
such as DDT and PCB, are still found in human serum.8  
Human development has been proven susceptible to disruption, predominantly 
throughout decisive stages, such as the periconceptional, embryonic, foetal, infant and 
pubertal periods.76-78 The developmental and physiological plasticity (partially owing to 
epigenetic modification of gene expression) that prevails in the perinatal period in 
response to changes in the intrauterine environment is evolutionarily beneficial, as it 
allows foetuses to adapt to prenatal and postnatal life. Yet, intrauterine exposure to ED 
may easily disrupt the foetal endocrine system, resulting in permanent changes that may 
lead to immediate outcomes as well as long-term adverse effects on reproduction and 
development, which may only become apparent during puberty or even later in life.79 
The timing of exposure may explain this differences:80 if ED exposure occurs during 
critical windows, adverse effects may be very drastic, including congenital 
abnormalities; on the other hand, if it occurs during sensitive, non-critical windows, 
detrimental outcomes may still arise, though possibly with reduced magnitude, 
including adult onset diseases and mild functional deficits. Supporting this hypothesis, 
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neonatal exposure to BPA for instance has been shown to have significant effects on 
spermatogenesis but adult exposure has not.81 
The prenatal period has become a significant research topic of ED exposure for two 
primary reasons: (a) the placenta does not protect the developing foetus from damaging 
chemicals, which may be biomagnified in some cases.82,83 BPA has low binding affinity 
to serum proteins such as the sex hormone-binding globulin (SHBG) or α-fetoprotein 
(AFP), which stop maternal sex hormones from crossing the placenta and affecting 
foetal development.84 Therefore, BPA and other ED may have access to 
hormone-sensitive foetal tissues and disrupt their proper development.85 (b) Since 
programming of the hypothalamus-pituitary-gonadal (HPG) axis occurs during this 
period, ED exposure at this stage may determine fertility in adulthood.81 It is worth 
mentioning millions of children are conceived by women while on contraceptive pills 
containing EE. Albeit most do not show conspicuous congenital abnormalities, 
long-term reproductive consequences may ensue in adulthood.85 Indeed, developmental 
exposure of both male and female rats to EE in doses similar to those found on 
contraceptive pills cause permanent reproductive abnormalities, including impaired 
fertility.86  
Breastfeeding is another significant source of exposure to ED, such as BPA.87 As many 
ED accumulate in fat-rich tissues such as the breast, breastfeeding exposes both the 
mother and the foetus to relatively high levels of these substances.88,89 In most reported 
cases, detrimental effects in the offspring occurred at doses that produce minimal or no 
effects in the maternal organism.11 For this reason, women of childbearing age, and 
specifically those who are pregnant or breastfeeding, constitute a population group of 
utmost importance regarding ED exposure.90 Likewise, children deserve special 
consideration, as they have proportionally higher exposures to ED, due to a higher food 
and water intakes than adults, leading to a potentially higher body burden of such 
chemicals.91 
Recent studies concluded that plastic packaging is an additional important source of ED, 
such as phthalates and BPA, in the average human diet. Repeated exposure of 
food-contact materials to UV light, heat, and acidic or alkaline contents may cause 
polymers to breakdown into monomers, which then leach into food and beverages.92 For 
instance, bottled water contains a complex mixture of ED, including those that leach 
from the bottle itself. Chronic intake of ED from bottled water is believed to have 
adverse effects on human fertility, particularly among sensitive population groups such 
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as infants and pregnant women.67 Food-contact materials can also be a relevant source 
of ED in dry foods.90 Examples include the reported migration of phthalates from 
recycled paperboard and plastic packaging into infant food.67,93 So far, there is no 
consistent total estimation of ED leaching from food-contact materials. 
The average diet exposes humans to a wide variety of synthetic ED. However, it also 
contains natural ED, such as phytoestrogens, which are nonsteroidal compounds that 
possess strong oestrogen-like biological activity.26,35 The potential health benefits of 
phytoestrogens and seeming absence of major long-term adverse effects have led to an 
increased consumption of these substances, mainly through soy-based food.94,95 Yet, 
high phytoestrogen intake, either chronically or during critical developmental periods, 
may trigger endocrine disruption.96 Studies have revealed that infants ingesting 
soy-based formulas may have a phytoestrogen serum concentration 13.000-22.000 times 
higher than endogenous oestrogen levels,97 and tenfold that of the average adult 
phytoestrogen levels, leading to concerns about the possible adverse effects of 
phytoestrogens on brain development and infertility later in life.10,98  
 
ED and the Central Nervous System 
Successful human reproduction requires appropriate morphological and physiological 
development of both male and female reproductive system. Gonadal hormones play a 
vital role in the development of these structures and are crucial for fertility. ED may 
modify endogenous steroidogenesis via negative and positive feedback, both locally and 
through the HPG axis, which works a delicate balance to maintain the homeostatic 
parameters required for reproduction.7  
Human HPG axis is active in utero and during the first year of life.99 Afterwards, 
gonadotropin secretion is reduced until puberty, when sequential endocrine changes in 
the secretion of gonadotropin-releasing hormone (GnRH), gonadotropins, and sex 
steroids set in motion the development of secondary sexual characteristics that will lead 
to sexual maturation, and hence the possibility to reproduce.100 Some PCB have been 
shown to alter GnRH synthesis101 and to decrease GnRH release by disrupting 
serotoninergic pathways.102 On the other hand, DDT and BPA stimulate 
glutamate-induced GnRH release.103  
Kisspeptin is broadly recognized as a fundamental activator of the HPG axis, at the 
onset of puberty.104 As many ED have been reported to alter sexual behaviour, puberty, 
and fertility, the kisspeptinergic system became an obvious object of research.100 In rats, 
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neonatal exposure to oestrogenic ED, such as BPA and genistein, induced variable 
degrees of kisspeptin suppression, possibly by reducing hypothalamic kisspeptin mRNA 
levels.105,106 The relative importance and prospective interaction of endocrine disruption 
at both these reproduction-controlling brain networks (GnRH and kisspeptin neurons) 
remains unclear. 
Numerous chemical signals regulate the development of the central nervous system. 
Particularly, sex steroids have prominent roles in the differentiation of several 
dimorphic neural circuits and behaviours, in addition to the development of primary 
and, later, secondary sexual characteristics.107,108 The developing brain is protected from 
excessive exposure to maternal sex hormones by proteins such as SHBG and AFP.109 
As BPA and other ED bypass this control mechanism, they may cross the immature 
blood-brain barrier16 and therefore disrupt the differentiation of sexually dimorphic 
areas (such as the dopaminergic, nitrergic, and kisspeptinergic systems), reversing the 
neurochemical phenotype, which adversely affects fertility and sexually differentiated 
behaviours in adulthood.110 Developmental exposure to BPA, MXC, and VCZ has been 
shown to produce gender-inadequate adult behaviours,111 possibly by disrupting specific 
neural pathways (eg. nitrergic fibres) that influence complex functions and behaviours 
such as those related to reproduction.112  
Intrauterine exposure to ED may impair the development and function of the HPG axis 
as a whole.110 In rats, perinatal exposure to environmentally relevant BPA doses, below 
the LOAEL, disrupted the HPG axis maturation, by inducing defective GnRH pulses 
and low serum gonadotropin levels up to adulthood, leading to infertility.113 
Long-lasting reproductive disorders induced by developmental ED exposure may be 
more likely to arise from a dysfunctional HPG axis than from impairments at 
reproductive organs.114 In fact, current evidence suggests the primary target of 
developmental ED exposure might be the hypothalamus and the pituitary gland rather 
than gonads themselves.108 
 
ED and the Male Reproductive System 
Epidemiological studies taking place over the last decades have reported an ominous 
growth in the incidence of male infertility, accompanied by decreasing sperm quality.115 
A large review of international studies shown that, over fifty years, the global average 
sperm count dropped by half (from 113 to 66 million/mL), reflecting an average yearly 
decrease of 1%, and sperm morphology and motility abnormalities significantly 
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increased.116 Amongst semen quality parameters, sperm motility is the most valuable 
independent predictor of male fertility.117 A subsequent larger study confirmed the 
declining sperm concentration at a yearly rate of 1.5-3%.118 However, those results are 
still questioned due to concerns about the study design.119  
Studies comparing male reproductive disorders amongst the Nordic-Baltic countries, 
which are geographically and socially closely related, have reported an east-west 
gradient showing higher reproductive tract abnormalities and infertility rates in 
Denmark as compared to Finland.120,121 Although genetic differences cannot be 
excluded, ED may more likely explain this geographical trend. Actually, significantly 
higher levels of ED were found in the breast milk of Danish women as compared to 
Finnish women.88 Moreover, several epidemiological studies have found an association 
between increased urinary and serum levels of ED, such as phthalates,122 PCB,123 
PBDE,124,125 and BPA,126 and inferior semen quality parameters, suggesting ED may be 
a contributing factor to male infertility.  
Male infertility is closely related to low semen quality (reflecting impaired 
spermatogenesis), congenital abnormalities of the reproductive system, and testicular 
cancer.96 Epidemiologic studies have shown a correspondence between temporal and 
geographic trends in semen quality and the incidence of cryptorchidism, hypospadias, 
and testicular cancer.127 These disorders have been regrouped under the term Testicular 
Dysgenesis Syndrome (TDS),128 as they are thought to arise from intrauterine disruption 
of proper testicular development and function, possibly through epigenetic 
modifications,129 as a result of individual genetic susceptibility influenced by ED 
exposure.130 In the mildest, most common cases of TDS, men have slightly decreased 
testicular volume in addition to poor semen quality and relatively low testosterone 
levels, while in the more severe cases there is cryptorchidism or hypospadias and an 
increased risk of testicular cancer.131 A subtle TDS may thus explain some of the 
idiopathic infertility cases, which constitute approximately half the men presenting at 
infertility clinics.132 ED exposure has been suggested to have triggered the escalation of 
mild to moderate TDS cases, whereas the most severe forms of this syndrome are 
undeniably related to genetic factors.133  
Current epidemiological data suggest that human developmental exposure to 
environmental levels of ED, such as phthalates, PCB and pesticides, is indeed connected 
to an increased risk of hypospadias and cryptorchidism.89,134-137 Hypospadias, a 
condition in which the urethral meatus is not at the tip of the glans but on the ventral 
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side of the penis, affects about 0.4% of males at birth and has been reported to have 
increased significantly over the last decades.138 ED are regarded as a contributing 
factor,4 since several of these substances, such as VCZ139 and phthalates140 consistently 
induce hypospadias in laboratory animals. 
Cryptorchidism is generally regarded as the failure of one or both testicles to descend 
into the scrotal sac and is the most common congenital abnormality in male children, 
affecting 2-4% full-term born males.120 One should keep in mind that the definition of 
cryptorchidism differs between authors, and this might influence the reported 
prevalence of this condition.141 Nonetheless, epidemiological studies conducted over the 
last decades suggest the incidence of cryptorchidism is on the rise.142 In adulthood, 
these men are frequently infertile due to disrupted spermatogenesis, and commonly 
show reduced testicular volume that correlates to reduced sperm quality and lower 
serum testosterone.143 Cryptorchidism currently embodies the best characterized risk 
factor for infertility and testicular cancer in adulthood.141 Testicular migration is a 
complex, two-stage process. ED exposure, in utero and after birth may explain the 
reported increasing incidence of cryptorchidism, due to a (a) reduction in insulin-like 
factor 3 (INSL3) expression in Leydig cells, disturbing the development of the 
gubernaculum, which is vital for transabdominal testicular migration;144 and (b) 
suppression of gonadotropin production, and impairment of steroidogenic enzymes in 
Leydig cells, resulting in relative testosterone deficiency, which is essential for 
transinguinal testicular descent.130 Exposure to some ED, such as PBDE, through 
breastfeeding has been correlated to cryptorchidism in new-borns.83 There have also 
been reports of an association between higher maternal urinary phthalate metabolites 
and higher testicular position in infant boys but not with actual cryptorchidism.134  
Testicular dysgenesis may result in early effects (e.g. hypospadias and cryptorchidism) 
as well as late consequences (e.g. infertility and testicular cancer).145 Delayed effects 
may be difficult to predict. Though, there are some signs that may indicate an increased 
risk of testicular cancer, such as low testicular volume and evidence of testicular 
microcalcifications on ultrasound.146 Over the last decades, testicular cancer rates have 
greatly increased in many developed countries, probably owing to ED exposure.147 As 
cancer registers are usually more accurate than those for congenital abnormalities, the 
former may be regarded as a proxy for fertility problems in the general population.148  
A large epidemiological study in adult Danish men found that infertile men had 
significantly lower serum testosterone/luteinizing hormone (LH) ratio than proven 
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fertile men, suggesting compromised Leydig cell function.149 Besides, those changes 
were more obvious among men with history of cryptorchidism. Consequently, 
decreased Leydig function (that may be secondary to Sertoli cell dysfunction) is 
presumably the main trait of TDS, either causally or as a consequence of developmental 
ED exposure, being accountable for androgen insufficiency, reduced genital volumes 
and impaired spermatogenesis in the adult.133,145  
The differentiation of the male reproductive system is entirely dependent on foetal 
testicular androgen production.150 As a transitory peak in testosterone levels is critical 
for appropriate male differentiation,151 disruption of androgen activity by ED during the 
virilisation period (around 8-14 weeks of human foetal development), will perhaps 
cause TDS.152 In experimental studies examining the effects of exposure to 
anti-androgenic ED, reduced anogenital distance (AGD) is an important reproductive 
endpoint,46 reflecting ineffective perineal virilisation.153 In animal models, 
developmental exposure to phthalates results in a syndrome of reproductive anomalies 
encompassing, cryptorchidism, testicular injury, reproductive tract malformations and 
shorter AGD.140 This pattern of effects, which parallels TDS, has been called the 
“phthalate syndrome” and its severity is dose-dependent.154 Similar to rodents, human 
male infants exhibit twice as long an AGD than female, and this distance can be used as 
a reliable marker of human virilisation.155 Developmental exposure to phthalates at 
environmental doses seems to cause reduced AGD in male infants, and severe forms of 
TDS are expected at higher doses of exposure.134,156 Recently, a study on children with 
hypospadias and cryptorchidism indicated that these conditions are associated with 
reduced AGD.157 Furthermore, in adults, shorter AGD correlates to poorer sperm 
quality parameters and therefore may be considered a predictor of male infertility.158  
Other anti-androgenic ED can induce TDS in animals: exposure to different doses of 
VCZ during critical periods produces a wide spectrum of reproductive disorders.159 In a 
study, all male rats exposed in utero to 20-100 mg/kg-bw/day of VCZ shown shorter 
AGD, hypospadias, and minute sperm counts.139 However, these ED exert their effects 
through different mechanism, as VCZ acts through AR antagonism, while phthalates 
inhibit INSL3 expression as well as other genes involved in testosterone synthesis.160 
Interestingly, chronic oral VCZ exposure may also alter the levels of several sperm 
proteins which are vital for fertilization.161 It is believed VCZ can induce such 
abnormalities in humans as well.22 Though average human ED exposure levels may be 
lower than those customarily used in animal studies, certain population clusters may be 
15 
 
exposed to higher levels.162 Actually, occupational pesticide exposure has been 
connected to male infertility owing to lower sperm quality, consequent to lower 
testosterone levels.135,163,164 In a recent epidemiological study, NSAID or 
acetaminophen consumption during pregnancy was shown to be directly related to a 
higher risk of cryptorchidism in male infants, and possibly other TDS traits, particularly 
if intake had taken place during more than one week or if there had been simultaneous 
ingestion of more than one of those drugs.25 Rats exposed to 150 mg/kg-bw/day of 
acetaminophen during foetal development, had AGD reductions comparable to that 
induced by phthalates.25 
Besides androgens, oestrogens also contribute to proper male reproductive system 
differentiation and fertility in adulthood,56,165 since both androgens and oestrogens 
reciprocally affect AR and ER expression throughout the male reproductive system.166 
A disproportionate oestrogenic exposure early in foetal life may therefore disturb the 
delicate androgen-oestrogen balance, leading to infertility.167  
ED may disrupt spermatogenesis by interfering with germ cells and 
spermatogenesis-supporting cells.168 Phthalate exposure is associated with male germ 
cell apoptosis in rats,168 as well as in humans.169 Furthermore, neonatal exposure to DES 
and EE increases the apoptosis rate throughout spermatogenesis, in rats.170 Testicular 
androgenic signalling may be compromised through several mechanisms that deregulate 
Leydig cell development and function.171 Many ED, including phthalates,77 PCB,172 
cypermethrin,19 and EE,24 hamper the steroidogenic response of Leydig cells by 
disrupting its enzymatic activity. PCB are also thought to decrease AR gene 
expression.173 Phthalates may disrupt hormone synthesis by down-regulating AR, ER, 
and steroidogenic enzymes via an AhR-dependent pathway.77 Some NSAID and 
acetaminophen lessen testosterone synthesis supposedly by reducing PG levels or 
through other unclear mechanisms.174 The link between phytoestrogens and semen 
quality parameters is still debated.26 Nevertheless, phytoestrogen exposure is thought to 
disrupt the late stages of spermatogenesis by interfering with the AR pathway.96 Some 
ED are thought to be Sertoli cell toxicants. Rats exposed to DES or EE in utero have a 
reduced Sertoli cell population in adulthood.170. Additionally, prenatal and neonatal 
mice exposed to BPA lessen the expression of Sertoli cell junctional proteins, a 
significant component of the blood-testis barrier, which may lead to germ cell loss 
within the seminiferous epithelium and consequently to infertility in adulthood.81,175 
Disruption of the HPG axis, consequently reducing testicular androgen production and 
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signalling, was demonstrated in the rat, following exposure to an array of ED, such as 
DES,170 PCB,101 and atrazine.18 Additionally, exposure of foetal human testis in vitro to 
dieldrin at doses far below average human body burden significantly impairs the 
development and function of Leydig cells, by antagonizing LH action.21 
Deleterious effects of ED may be more severe in individuals with some genetic 
susceptibility, assuming the same exposure circumstances. There are AR and ER-α 
genetic polymorphisms that cause mild functional impairments176,177 and are expected to 
lead to infertility, and possibly more severe forms of TDS, when combined with ED 
exposure.130 Indeed, a correlation has been reported between cryptorchidism and 
specific, ED-vulnerable ER-α polymorphisms.178 Furthermore, despite current 
epidemiological evidence does not support a unequivocal association between PCB and 
DDT and TDS features,179 among European men with measurable serum levels of these 
substances, those having particular AR polymorphisms were found to have significantly 
inferior sperm quality.180 
 
ED and the Female Reproductive System 
Female fertility depends upon a functional reproductive system, capable of producing 
fertilizable oocytes through folliculogenesis, a multi-stage process which requires 
specific endocrine signals.181 Both oestrogens and androgens are essential for 
maintaining HPG homeostasis, which is crucial for follicular development and 
ovulation, and ultimately female fertility.182 Proper differentiation of the female 
reproductive system is regulated by sex hormones, particularly oestrogens, but it 
proceeds even in their absence, being regarded as the default developmental pathway.183 
Nevertheless, oestrogen signalling pathway overstimulation during critical 
developmental periods is known to result in several irreversible abnormalities.23,184 All 
components of the female reproductive system are prone to ED action particularly 
during the developmental period.185 The array of female reproductive disorders where 
ED have been implicated is fairly large, comprising endometriosis, disorders of the 
uterus, as well as disorders of the ovary, such as premature ovarian failure (POF), 
oocyte aneuploidy and polycystic ovary syndrome (PCOS), all of which may result in 
infertility.11,186 Since these disorders may arise from impaired ovarian development and 
function, the term Ovarian Dysgenesis Syndrome (ODS) has recently been suggested as 
the female form of TDS.187 The incidence of ODS traits is growing.76  
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Data concerning ED effects on female reproductive system and fertility are scant, when 
compared to the male counterpart, in both human epidemiological studies and 
experimental literature.188 Still, a correlation between developmental ED exposure and 
long-term effects is suggested.185 For instance, women whose mothers had high 
maternal serum concentration of DDT during pregnancy were found to have a 
significantly higher risk of infertility.189 In adult women, high serum concentration of 
ED, such as BPA, is associated with a variety of female reproductive system disorders, 
including endometrial hyperplasia, PCOS, and infertility.190 Occupational exposure to 
ED such as pesticides, plastics, and other industrial chemicals is a risk factor for female 
infertility.191 
Many ED can potentially hamper the differentiation of the female reproductive system, 
both in utero and after birth, by disrupting the appropriate expression of 
oestrogen-regulated genes.185 The development of the female reproductive system is 
regulated by the differential expression of Hox genes in the Müllerian duct.192 
Disruption of the precise chronological regulation of Hoxa10 by ED, that either increase 
(e.g. BPA) or down-regulate (e.g. DES and MXC) the expression of this gene, has been 
shown to lead to uterine abnormalities and infertility.193,194 In extreme cases, Müllerian 
agenesis may occur.195 DES has also been found to contribute to uterine abnormalities 
by reducing the expression of other developmental genes, such as the Wnt7 or Msx2 
genes.196 Intrauterine exposure to genistein disrupts the proper differentiation of the 
female reproductive system, in a dose-dependent response.197  
Endometriosis is accountable for one third of infertile women, affecting up to 10% of 
women of childbearing age and causing infertility in about half those women.198 This 
condition is undeniably related to hormonal disturbances, and ED have recently been 
proposed as a possible contributing factor for the development and exacerbation of this 
disorder.188,199 Indeed, a significantly higher BPA200 and phthalate201 serum 
concentration has been found in women with endometriosis. Women exposed to DES in 
utero may have an 80%-higher risk of endometriosis than unexposed women.202 This 
condition can be regarded as a developmental disorder. Experimental studies support 
this hypothesis, as intrauterine exposure of mice to BPA203 or TCDD204 produces an 
endometriosis-like adult uterine phenotype. Even though several epidemiological 
studies have failed to prove an association between elevated serum levels of TCDD or 
PCB and the development of endometriosis,205 a recent study shown that women with 
endometriosis have significantly higher concentrations of these ED in peritoneal fluid 
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than healthy women,206 possibly leading to chronic inflammation, which may result in 
greater oestrogen synthesis, and stimulation of endometrial cells derived from 
retrograde menstruation.207 
There are growing concerns about the reproductive outcomes of ovarian exposure to ED 
during foetal development and after birth.208 It is largely agreed that ED can damage the 
testis and the ovaries in distinct ways, consistent with their differing intrinsic properties: 
unlike male germ cells, female germ cells are a fixed population. Therefore, exposure of 
hormone-responsive, primordial and preantral follicles to ED may lead to impaired 
folliculogenesis or even to depletion of follicular reserves, which may ultimately result 
in POF.209 This is a syndrome consequent to impaired ovarian function before the age of 
40, affecting about 1% of women.210 Folliculogenesis-supporting cells, such as 
granulosa and theca cells, which are crucial for ovarian steroidogenesis and oocyte 
development, are also a target of ED.211,212 Current data suggest chronic exposure to 
TCDD at environmental levels (lower than 1 ng/kg-bw/day) may induce POF in female 
rats, leading to low serum oestradiol levels without a substantial reduction of preantral 
follicles.15 This is thought to occur chiefly through the inhibition of follicle-stimulating 
hormone (FSH)-stimulated LH receptor expression,213 and the inhibition of genes 
responsible for steroidogenesis.214 Some ED, such as atrazine, have been shown to 
disrupt folliculogenesis in adult rats, inducing follicular atresia and the development of 
multiple-oocyte follicles (MOF).215 Developmental exposure to PCB has been found to 
negatively affect oocyte development, to induce follicular atresia and to impair oocyte 
quality in mice13 and in farm animals.216 Neonatal mice exposed to environmental doses 
of genistein show MOF in adulthood.217,218 Genistein exposure in adulthood inhibits the 
transition of primordial to primary follicles, impairing ovulation.219 Postnatal exposure 
to high doses of BPA has also been shown to increase the number of MOF in mice.220 
Furthermore, intrauterine BPA exposure has been linked to gross meiotic aberrations, 
leading to aneuploidy and follicular atresia.221 Actually, an inverse correlation between 
BPA serum levels and oocyte quality has been suggested in women undergoing in vitro 
fertilization (IVF) procedures.222 MOF oocytes from DES-exposed mice are less likely 
to be fertilized through IVF, suggesting DES adversely affects oocyte quality.223 DDT 
metabolites and MXC have been shown to disrupt the early steps of steroidogenesis in 
granulosa cells.224 Additionally, MXC inhibits folliculogenesis, possibly by stimulating 
the production of anti-müllerian hormone directly.225 Phthalates induce oestrogen 
metabolism, thus may disrupt follicular differentiation.226 
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PCOS, which consists mainly of chronic anovulation and hyperandrogenemia that often 
lead to infertility, is a common endocrine disorder affecting 5-8% of women of 
childbearing age.227 ED that stimulate hyperandrogenemia may elicit PCOS in women 
who have genetic susceptibility.228 Higher serum BPA levels have been reported in 
women with PCOS, as compared to healthy women.190,229 In lambs, developmental 
exposure to BPA and MXC leads to smaller and hindered LH surges, and consequently 
to anovulatory cycles, as well as ovarian abnormalities, and metabolic disorders related 
to PCOS.230 
 
Transgenerational effects of ED 
ED have been shown to disrupt the development of the human reproductive system, 
impairing fertility not only in the directly exposed offspring but also in subsequent 
generations. During the mid-twentieth century, DES was extensively prescribed for 
preventing miscarriages. However, DES use in pregnant women was banned in the 
1970s because of increased frequency of vaginal carcinoma and uterine abnormalities 
later found in the daughters of those women.23 Since then, a vast array of reproductive 
system abnormalities leading to infertility, among other adverse effects, have been 
reported in both male and female offspring of women treated with DES, and validated 
in experimental studies.98,231 Recently, a French epidemiologic study has shown that 
pregnant women who were exposed to DES gave birth to children with reproductive 
system abnormalities.232 Furthermore, grandchildren born to daughters with Müllerian 
abnormalities had higher incidence of reproductive abnormalities. Other ED may have 
transgenerational effects: the offspring of TCDD-exposed mice was found to have 
fertility disorders up to third non-exposed generation.204 It has been reported that 
perinatal exposure to low PCB levels induces more severe outcomes in the following 
generation.233 Indeed, both male and female mice exposed in utero to environmental 
levels of PCB presented impaired gamete quality and permanent morphological 
abnormalities of the reproductive system, and so did the following two generations.13 
Epigenetic mechanisms may play an important role in the transgenerational effects of 
ED. The epigenome refers to changes made in gene expression by altering DNA 
structure without changing the actual genomic sequence. Epigenetic processes include 
DNA methylation, posttranslational histone modifications, and chromatin 
remodelling.234 These changes can have temporary or durable – even transgenerational – 
effects.235 ED capable of modulating genomic imprinting may induce persistent, 
20 
 
transgenerational changes.236 Epigenetic changes of some genes, such as the AR gene, 
transmitted through female germ line, could explain the transgenerational effects of 
DES.232 BPA, phthalates, and VCZ have been shown to alter gene expression and 
imprinting patterns in mouse embryos.237 In experimental studies, epigenetic 
modifications of gamete DNA at imprinted loci triggered by ED exposure affected the 
non-exposed following generations, through either the male or the female germ line. 
Transient developmental exposure of male rats to VCZ and MXC during the 
epigenetic-reprogramming stage was shown to induce shorter AGD and to adversely 
affect spermatogenesis, leading to infertility; these effects were transmitted through the 
male germ line to almost every male up to the fourth generation.235 More recently, an 
industry-sponsored research group failed to report transgenerational effects of VCZ.238 
Perinatal exposure to BPA can induce the down-regulation of AR and ER gene 
expression, as well as co-regulator genes, leading to impaired spermatogenesis; these 
modifications may be imprinted on the germ line, causing abnormal reproductive 
function up to the following two generations, which were not exposed to BPA.239 
Current data suggest epigenetic modifications induced by ED may have drastic adverse 
effects on human fertility, as the entire reproductive system is very sensitive to these 
compounds.185,234 In particular, male germ cells are the most vulnerable cells, as they 
have distinctive methylation patterns and epigenetic markers.234 So far, no major 
progresses have occurred in the medical management of poor sperm quality. As the 
current assisted reproductive techniques such as IVF and intracytoplasmic sperm 
injection do not necessarily address the underlying problem, its escalating use, 
regardless of cause, may accidentally convey serious genetic anomalies.9 Thus, through 
epigenetic changes, ED can perhaps have negative evolutionary effects, by permanently 
altering DNA structure, hence facilitating genetic mutations.240 
 
Synergistic effects of ED 
In order to study the detrimental effects in the development of both male and female 
reproductive system, most experimental studies have used a single ED during short 
exposure periods, frequently during critical developmental stages, in doses that 
sometimes exceeded environmental levels and human expected body burdens. However, 
humans and wildlife are constantly exposed to countless ED simultaneously, generally 
at low levels, which may act synergistically to produce endocrine disruption at doses far 
below individual LOAEL, if there is enough overall exposure.241 Indeed, sheep exposed 
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to sewage sludge, which contains many known ED, shown impaired GnRH 
expression.242 Additionally, a study addressing the adverse effects of developmental 
exposure of rats to a mixture of diverse-acting anti-androgenic ED, including VCZ and 
phthalates, has shown cumulative synergistic effects regarding the incidence of 
hypospadias and cryptorchidism.243 Furthermore, it has been shown that more than half 
the mice exposed in utero to a mixture of AR antagonists, including VCZ, developed 
hypospadias at individual drug doses that would not have caused hypospadias at all.244  
In view of recent evidence, a number of brief high-dose exposures to customary drugs, 
as NSAID or acetaminophen,25,174 on top of the potential long-lasting hormonal 
disruption by ubiquitous ED, particularly during critical developmental periods, are 
suspected to have a serious impact on human reproductive health. Additionally, it is 
hypothesized that even low levels of oestrogenic ED, particularly phytoestrogens, may 
be capable of altering cell responsiveness to other ED, such as anti-androgenic ED, 
thereby inducing wider negative effects when there is concomitant exposure.141 In this 
matter, a mixture of genistein and other ED has also been found to elicit a quicker 
capacitation and acrosome loss in human spermatozoa in vitro, rather than each 
compound alone, rendering them unable to complete fertilization.245  
Moreover, a study in rats shown chronic ingestion of a low-dose genistein and VCZ 
mixture (at 1 mg/kg-bw/day each), from conception through adulthood, brought forward 
more severe changes on the male reproductive system and lower semen quality 
compared to individual exposure to each of these ED, at the same dose, suggesting 
genistein may potentiate the effects of VCZ.246 In contrast, there are studies reporting 
genistein may reduce the detrimental effects of VCZ on male germ cells, using the same 
experimental procedure from conception to birth.247 
Altogether, different ED may have cumulative effects on the same physiological process 
or intensify the effects of one another through diverse and distinct mechanism of action, 
leading to more severe consequences than previously ascertained. Yet, their net effects 
may be reciprocally invalidated, depending on the exposure period (either chronically or 
during critical developmental stages), as well as individual and global exposure doses. 
All in all, chronic exposure to a mixture of ED may induce worse outcomes than a 
single high dose exposure, thus may seriously affect human reproductive system 
differentiation and contribute to human infertility. 
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Conclusion 
This paper has reviewed and summarized the existing evidence regarding ED as 
contributing agents to the rising rates of human infertility. Although the number of 
studied and mentioned ED is not comprehensive, an adequate amount of data has 
accumulated demonstrating that ED may have deleterious effects on human fertility via 
numerous mechanisms. ED may be blamed for the rising incidence of human 
reproductive disorders, and may also explain some idiopathic infertility cases, both in 
men and women, although the influence of already well-known lifestyle-related 
aspects248 (such as alcohol consumption during pregnancy as well as parental smoking) 
on human fertility should not be neglected. 
Endocrine disruption is a serious Public Health problem that must not be ignored. 
Legislation concerning ED must take into account current scientific knowledge.249 
Additionally, regulatory authorities should endorse preventive measures regarding the 
exposure to ED, such as limiting the utilization of ED in industry worldwide. 
Meanwhile, the general population might reduce ED exposure by following some 
simple yet important advices, such as (a) choose glass over plastics, (b) avoid using the 
same plastic containers repeatedly or plastic wrapping to microwave food, (c) reduce 
consumption of fatty animal products, (d) prefer pesticide-free vegetables and fruits, 
and (e) avoid excessive utilization of cosmetics and other personal care items, 
particularly during pregnancy. Precautionary avoidance of exposure to well-known and 
putative ED is a prudent attitude. 
Further research is needed to assess the use, persistency and latent risks of the known 
ED (even those banned decades ago), in addition to identify potential 
endocrine-disruptive activity in other chemicals aiming to discourage their continued 
use, in order to protect wildlife and humans, particularly developing foetuses, neonates 
and young children, from permanent effects on fertility. Prospective epidemiological 
studies on this subject should be performed. For instance, it would be important to 
examine adult fertility and hormonal parameters of infants fed soy-based formula or 
cow milk formula-fed using baby bottles made of different substances, as opposed to 
breastfed infants; as well as of infants inadvertently exposed to contraceptive hormones 
during the early foetal development.  
Future research agenda should focus on assessing the dose-effect curve of known ED 
even at minute concentrations, and also on measuring the impact of mixed exposure of 
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low doses of different ED and their possible effects on future generations, relating to 
genetic polymorphisms, especially during gametogenesis and foetal development.  
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